Deep Characterization of Aspartic Acid Isomerism Using High-Resolution Cyclic™ Ion Mobility and Electron-Capture Dissociation

Importance of the Topic

Characterization of aspartic acid isomerism is critical in biotherapeutics because subtle changes in amino acid stereochemistry can alter drug safety and efficacy.
Conventional LC-MS peptide mapping often fails to differentiate L-Asp, D-Asp, L-isoAsp and D-isoAsp due to identical masses and similar structures.

Study Objectives and Overview

This work demonstrates a combined workflow of high-resolution cyclic ion mobility spectrometry and electron capture dissociation for comprehensive separation and identification of Asp isomers in monoclonal antibody peptides.
The approach was applied first to synthetic peptide mixtures and then to spiked tryptic digests of trastuzumab.

Methodology

Monoclonal antibody samples were enzymatically digested to generate peptides with aspartic acid variants.
Synthetic peptides representing all four Asp isomers were analyzed both as a pure mixture and spiked into the digest at 5% levels.
Initial separation by liquid chromatography revealed only partial resolution of isomeric peaks.

Instrumental Setup

Analyses were performed on the SELECT SERIES Cyclic IMS Mass Spectrometer equipped with an integrated ECD cell.
Multipass cyclic IMS separations (up to 10 passes) provided enhanced ion mobility resolution.
ECD fragmentation was carried out post-IMS to generate diagnostic fragment ions.

Main Results and Discussion

Liquid chromatography showed overlapping peaks for three of the four isomers, especially at low abundance.
Multipass cyclic IMS achieved baseline separation of all four Asp isomers in both synthetic and spiked samples by resolving differences in ion mobility.
Post-IMS ECD fragmentation produced c(n−1)+57 Da and z(m−n−1)−57 Da marker ions that unambiguously identify isoAsp residues.
This combination enabled confident discrimination between Asp and isoAsp species.

Practical Benefits and Applications

This workflow accelerates biotherapeutic characterization by reducing reliance on extended chromatographic gradients and synthetic standards.
Enhanced separation and specific fragmentation improve quantification accuracy of isomeric modifications in quality control and research settings.

Future Trends and Applications

Integration of high-resolution ion mobility and electron capture dissociation is poised to expand analysis of other isomeric post-translational modifications.
Implementation in automated multi-attribute methods could streamline workflows in industrial QC.
Advances in instrumentation may further improve throughput and sensitivity.

Conclusion

The combined cyclic IMS-ECD approach represents a significant advancement for deep characterization of aspartic acid isomerism in biotherapeutics.
It delivers comprehensive separation, definitive isomer identification, and practical workflow enhancements.

Reference

• Lambeth TR, Riggs DL, Talbert LE, Tang J, Coburn E, Kang AS, et al. ACS Cent Sci. 2019;5(8):1387–95.
• Fujii N, Sakaue H, Sasaki H, Fujii N. J Biol Chem. 2012;287(47):39992–40002.
• Eakin CM, Miller A, Kerr J, Kung J, Wallace A. Front Pharmacol. 2014;5:87.
• Nytka M, Wan J, Tureček F, Lemr K. J Am Soc Mass Spectrom. 2024;35(8):1733–42.
• Colson E, Decroo C, Cooper-Shepherd D, Caulier G, Henoumont C, Laurent S, et al. J Am Soc Mass Spectrom. 2019;30(11):2228–37.
• Wisanpitayakorn P, Jariyasopit N, Duangkumpha K, Goh JX, Palmer ME, Sirivatanauksorn Y, et al. ACS Meas Sci Au. 2025;5(1):109–19.
• Berthias F, Cooper-Shepherd DA, Holck FHV, Langridge JI, Jensen ON. Anal Chem. 2023;95(29):11141–8.
• Su Y, Zhao B, Zhang L, Shen B, Guo C, Xiao H, et al. Anal Chem. 2025;97(4):2223–31.
• Cournoyer JJ, Pittman JL, Ivleva VB, Fallows E, Waskell L, Costello CE, et al. Protein Science. 2005;14(2):452–63.
• Kjeldsen F, Haselmann KF, Budnik BA, Jensen F, Zubarev RA. Chem Phys Lett. 2002;356(3):201–6.
• Cooper-Shepherd D. Waters Application Note 720008287. September 2025.